OTLC
ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. (OTLC)
$06
About ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Details
Daily high
$0.06
Daily low
$0.05
Price at open
$0.05
52 Week High
$0.07
52 Week Low
$0.02
Market cap
23.8M
Dividend yield
0.00%
Volume
30,155
Avg. volume
144,027
P/E ratio
-5.26
ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. News
Details
Daily high
$0.06
Daily low
$0.05
Price at open
$0.05
52 Week High
$0.07
52 Week Low
$0.02
Market cap
23.8M
Dividend yield
0.00%
Volume
30,155
Avg. volume
144,027
P/E ratio
-5.26